Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 15 | 2018 | 68 | 2.940 |
Why?
|
| Erythrocyte Transfusion | 16 | 2022 | 72 | 2.750 |
Why?
|
| Anemia | 14 | 2022 | 119 | 1.830 |
Why?
|
| High-Frequency Ventilation | 4 | 2016 | 5 | 1.740 |
Why?
|
| Critical Illness | 18 | 2022 | 329 | 1.690 |
Why?
|
| Respiratory Insufficiency | 4 | 2018 | 148 | 1.160 |
Why?
|
| Child | 29 | 2023 | 4193 | 1.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 52 | 0.840 |
Why?
|
| Hospitalization | 3 | 2017 | 1292 | 0.820 |
Why?
|
| Hospice Care | 1 | 2023 | 62 | 0.820 |
Why?
|
| Palliative Care | 1 | 2023 | 214 | 0.740 |
Why?
|
| Evidence-Based Medicine | 13 | 2022 | 442 | 0.730 |
Why?
|
| Respiration, Artificial | 4 | 2016 | 292 | 0.670 |
Why?
|
| Isoflurane | 2 | 2012 | 17 | 0.660 |
Why?
|
| Anesthetics, Inhalation | 2 | 2012 | 18 | 0.660 |
Why?
|
| Child, Preschool | 13 | 2018 | 1794 | 0.600 |
Why?
|
| Critical Care | 15 | 2022 | 399 | 0.600 |
Why?
|
| Hemoglobins | 3 | 2018 | 133 | 0.600 |
Why?
|
| Hemorrhage | 4 | 2022 | 260 | 0.560 |
Why?
|
| Infant | 11 | 2022 | 1493 | 0.530 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2016 | 10 | 0.520 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 140 | 0.490 |
Why?
|
| Hypoxia | 1 | 2016 | 112 | 0.470 |
Why?
|
| Antidotes | 1 | 2014 | 20 | 0.450 |
Why?
|
| Poisoning | 1 | 2014 | 31 | 0.440 |
Why?
|
| Attitude to Death | 1 | 2012 | 16 | 0.400 |
Why?
|
| Group Processes | 1 | 2012 | 41 | 0.400 |
Why?
|
| Humans | 35 | 2023 | 59428 | 0.400 |
Why?
|
| Bronchial Spasm | 1 | 2012 | 8 | 0.390 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 57 | 0.390 |
Why?
|
| Phlebotomy | 1 | 2012 | 7 | 0.390 |
Why?
|
| Naloxone | 1 | 2011 | 57 | 0.350 |
Why?
|
| Narcotic Antagonists | 1 | 2011 | 121 | 0.320 |
Why?
|
| Environmental Exposure | 1 | 2011 | 208 | 0.320 |
Why?
|
| Consensus Development Conferences as Topic | 2 | 2018 | 13 | 0.310 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 692 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 704 | 0.290 |
Why?
|
| Infant, Newborn | 7 | 2018 | 1286 | 0.290 |
Why?
|
| Buprenorphine | 1 | 2011 | 181 | 0.290 |
Why?
|
| Athetosis | 1 | 2007 | 2 | 0.280 |
Why?
|
| Atracurium | 1 | 2007 | 2 | 0.280 |
Why?
|
| Status Asthmaticus | 1 | 2007 | 6 | 0.270 |
Why?
|
| Chorea | 1 | 2007 | 10 | 0.270 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2007 | 12 | 0.270 |
Why?
|
| Adolescent | 7 | 2018 | 5843 | 0.250 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2007 | 119 | 0.240 |
Why?
|
| Internship and Residency | 1 | 2012 | 747 | 0.230 |
Why?
|
| Age Distribution | 2 | 2014 | 249 | 0.200 |
Why?
|
| Community Health Services | 1 | 2023 | 120 | 0.200 |
Why?
|
| New England | 2 | 2014 | 267 | 0.190 |
Why?
|
| Male | 10 | 2016 | 27773 | 0.190 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 34 | 0.190 |
Why?
|
| Transfusion Reaction | 2 | 2018 | 44 | 0.190 |
Why?
|
| Liquid Ventilation | 1 | 2001 | 4 | 0.180 |
Why?
|
| Supine Position | 1 | 2001 | 31 | 0.180 |
Why?
|
| Prone Position | 1 | 2001 | 28 | 0.180 |
Why?
|
| Fluoroscopy | 1 | 2001 | 62 | 0.180 |
Why?
|
| Fluorocarbons | 1 | 2001 | 34 | 0.180 |
Why?
|
| Pain | 1 | 2023 | 397 | 0.180 |
Why?
|
| Drug Monitoring | 1 | 2001 | 115 | 0.170 |
Why?
|
| Blood Specimen Collection | 2 | 2012 | 19 | 0.170 |
Why?
|
| Female | 9 | 2016 | 30753 | 0.160 |
Why?
|
| Thalassemia | 1 | 2018 | 4 | 0.150 |
Why?
|
| Anemia, Hemolytic | 1 | 2018 | 12 | 0.150 |
Why?
|
| Shock, Hemorrhagic | 1 | 2018 | 19 | 0.150 |
Why?
|
| Shock | 1 | 2018 | 31 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 22 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 61 | 0.150 |
Why?
|
| Health Personnel | 1 | 2021 | 342 | 0.140 |
Why?
|
| Length of Stay | 2 | 2014 | 779 | 0.140 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 1 | 2017 | 14 | 0.140 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 105 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2018 | 150 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 94 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2016 | 3069 | 0.140 |
Why?
|
| Patient Care | 1 | 2017 | 78 | 0.130 |
Why?
|
| Quality of Life | 1 | 2023 | 1138 | 0.130 |
Why?
|
| Splenic Neoplasms | 1 | 2016 | 8 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2014 | 6077 | 0.130 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 129 | 0.130 |
Why?
|
| Time Factors | 3 | 2016 | 3620 | 0.130 |
Why?
|
| Propensity Score | 1 | 2016 | 144 | 0.120 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 106 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 125 | 0.120 |
Why?
|
| Sepsis | 1 | 2018 | 274 | 0.120 |
Why?
|
| Erythrocyte Count | 3 | 2018 | 15 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2012 | 1926 | 0.110 |
Why?
|
| Accidents | 1 | 2014 | 14 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 674 | 0.110 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 229 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 2051 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 747 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 276 | 0.110 |
Why?
|
| Risk Factors | 3 | 2012 | 4990 | 0.110 |
Why?
|
| Suicide, Attempted | 1 | 2014 | 105 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 331 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 402 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2016 | 430 | 0.100 |
Why?
|
| Terminally Ill | 1 | 2012 | 17 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 678 | 0.100 |
Why?
|
| Platelet Transfusion | 2 | 2022 | 12 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 310 | 0.100 |
Why?
|
| Drug Overdose | 1 | 2014 | 126 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 47 | 0.090 |
Why?
|
| Respiratory Function Tests | 1 | 2012 | 189 | 0.090 |
Why?
|
| Cause of Death | 1 | 2012 | 210 | 0.090 |
Why?
|
| Canada | 2 | 2010 | 147 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 244 | 0.090 |
Why?
|
| Drug Storage | 1 | 2011 | 21 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 403 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1482 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2014 | 342 | 0.090 |
Why?
|
| Medical Audit | 1 | 2011 | 58 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 450 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 584 | 0.090 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 34 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2011 | 355 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2010 | 146 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2012 | 5287 | 0.080 |
Why?
|
| Patient Safety | 1 | 2012 | 238 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 1231 | 0.070 |
Why?
|
| Incidence | 1 | 2012 | 1239 | 0.070 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 147 | 0.070 |
Why?
|
| Ventilator Weaning | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2012 | 2376 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2517 | 0.060 |
Why?
|
| Young Adult | 1 | 2012 | 4273 | 0.050 |
Why?
|
| Blood Component Transfusion | 1 | 2022 | 8 | 0.050 |
Why?
|
| Plasma | 1 | 2022 | 35 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 88 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2338 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2001 | 14 | 0.050 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2001 | 43 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2001 | 60 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2001 | 57 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2001 | 89 | 0.040 |
Why?
|
| Random Allocation | 1 | 2001 | 193 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 287 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2000 | 30 | 0.040 |
Why?
|
| Lung Injury | 1 | 2000 | 32 | 0.040 |
Why?
|
| Swine | 1 | 2001 | 355 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2001 | 230 | 0.040 |
Why?
|
| IgA Deficiency | 1 | 2018 | 3 | 0.040 |
Why?
|
| United States | 2 | 2010 | 7429 | 0.040 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2018 | 7 | 0.040 |
Why?
|
| Vital Signs | 1 | 2018 | 11 | 0.040 |
Why?
|
| Decision Trees | 1 | 2018 | 51 | 0.040 |
Why?
|
| Acute Disease | 1 | 2000 | 659 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 75 | 0.040 |
Why?
|
| Survival Rate | 1 | 2000 | 801 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 193 | 0.030 |
Why?
|
| Animals | 3 | 2016 | 19660 | 0.030 |
Why?
|
| Albumins | 1 | 2016 | 34 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2016 | 40 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2016 | 90 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 259 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 178 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 186 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 137 | 0.030 |
Why?
|
| Dependovirus | 1 | 2022 | 652 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2022 | 733 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 165 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 292 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 357 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1505 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 942 | 0.020 |
Why?
|
| Materials Management, Hospital | 1 | 2010 | 2 | 0.020 |
Why?
|
| Adult | 1 | 2000 | 15694 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 10300 | 0.010 |
Why?
|